XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Segments (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Schedule of net sales, adjusted EBITDA and certain other measures by reportable segment
The following tables present Net Sales, Adjusted EBITDA and certain other measures for the reportable segment and total Company operations for the three months ended March 31, 2019 and 2018. Adjusted EBITDA is used as a performance metric by the CODM in determining how to allocate resources and assess performance.
 
Three Months Ended March 31, 2019
(in thousands)
Net Sales
 
Gross Profit
 
Depreciation & Amortization
 
Adjusted EBITDA
Geographic divisions
$
825,405

 
$
216,122

 
$
16,147

 
$
73,768

Other reconciling items

 

 
645

 
(19,368
)
 
$
825,405

 
$
216,122

 
$
16,792

 
 

 
Three Months Ended March 31, 2018
(in thousands)
Net Sales
 
Gross Profit
 
Depreciation & Amortization
 
Adjusted EBITDA
Geographic divisions
$
834,202

 
$
199,084

 
$
15,211

 
$
63,674

Other reconciling items

 

 
470

 
(16,494
)
 
$
834,202

 
$
199,084

 
$
15,681

 
 

Reconciliation to consolidated financial statements
Reconciliation to consolidated financial statements:
 
Three Months Ended March 31,
(in thousands)
2019
 
2018
Income before income taxes
$
26,350

 
$
19,998

Interest expense
6,038

 
5,982

Interest income
(941
)
 

Depreciation and amortization
16,792

 
15,681

Merger and integration costs
2,790

 
1,687

Non-cash stock compensation expense
2,915

 
1,775

Acquisition costs
580

 
234

Other items (a)
(124
)
 
1,823

Adjusted EBITDA of other reconciling items
19,368

 
16,494

Adjusted EBITDA of geographic divisions reportable segment
$
73,768

 
$
63,674


(a) For the three months ended March 31, 2019, represents the effect of the settlement of pending litigation for an amount below what was previously accrued. See Note 9 for further details. For the three months ended March 31, 2018, represents costs incurred in connection with the departure of the Company’s former chief executive officer and the search for his permanent replacement.